Efficacy and functionality of lipoprotein OprI from Pseudomonas aeruginosa as adjuvant for a subunit vaccine against classical swine fever

Vaccine

Volumn 24, Issue 22, 2006, Pages 4757-4768

  Rau, Henriette ^a   Revets, Hilde ^b   Cornelis, Pierre ^b   Titzmann, Anja ^a   Ruggli, Nicolas ^a   McCullough, Kenneth C ^a   Summerfield, Artur ^a  

^a INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Adjuvant; Classical swine fever; Pigs; Subunit vaccine; Toll like receptor ligands

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CLASSICAL SWINE FEVER VIRUS VACCINE; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN E2; GLYCOPROTEIN E2 PLUS LIPOPROTEIN OPRI PLUS NONSTRUCTURE PROTEIN 3 VACCINE; GLYCOPROTEIN E2 PLUS NONSTRUCTURE PROTEIN 3 VACCINE; LIPOPROTEIN; LIPOPROTEIN OPRI; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTRUCTURAL PROTEIN 3; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; NONHUMAN; PESTIVIRUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SWINE; SWINE DISEASE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; CLASSICAL SWINE FEVER VIRUS; CYTOKINES; DENDRITIC CELLS; INTERFERON TYPE II; INTERFERON-ALPHA; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; PHENOTYPE; PSEUDOMONAS AERUGINOSA; SWINE; VACCINES, SUBUNIT; VIRAL VACCINES;

EID: 33646853176     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.03.028     Document Type: Article

References (57)

1. Armengol E., Wiesmuller K.H., Wienhold D., et al. Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J Gen Virol 83 Pt 3 (2002) 551-560
2. Aynaud J.M. Classical swine fever and related viral infections (1988), Martinus Nijhoff, Boston pp. 165-180
3. Balmelli C., Ruggli N., McCullough K., and Summerfield A. Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J Leukoc Biol 77 Pt 6 (2005) 923-933
4. Balmelli C., Vincent I.E., Rau H., Guzylack-Piriou L., McCulloug K., and Summerfield A. FcgammaRII-dependent sensitisation of natural interferon producing cells for virus infection and interferon-alpha response. Eur J Immunol 35 Pt 8 (2005) 2406-2415
5. Bensaude E., Turner J.L., Wakeley P.R., et al. Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells. J Gen Virol 85 Pt 4 (2004) 1029-1037
6. Bertoni G., Kuhnert P., Peterhans E., and Pauli U. Improved bioassay for the detection of porcine tumor necrosis factor using a homologous cell line: PK(15). J Immunol Methods 160 2 (1993) 267-271
7. Bouma A., de Smit A.J., de Kluijver E.P., Terpstra C., and Moormann R.J. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet Microbiol 66 2 (1999) 101-114
8. Carrasco C.P., Rigden R.C., Schaffner R., et al. Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104 2 (2001) 175-184
9. Carrasco C.P., Rigden R.C., Vincent I.E., et al. Interaction of classical swine fever virus with dendritic cells. J Gen Virol 85 Pt 6 (2004) 1633-1641
10. Cornelis P., Sierra J.C., Lim Jr. A., et al. Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli. Biotechnology (NY) 14 2 (1996) 203-208
11. Cote-Sierra J., Bredan A., Toldos C.M., et al. Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major. Infect Immun 70 1 (2002) 240-248
12. Cote-Sierra J., Jongert E., Bredan A., et al. A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination. Gene 221 1 (1998) 25-34
13. Dahle J., and Liess B. Assessment of safety and protective value of a cell culture modified strain "C" vaccine of hog cholera/classical swine fever virus. Berl Munch Tierarztl Wochenschr 108 1 (1995) 20-25
14. de Smit AJ, Van de Wetering G, Colijn EC, et al. Evaluation of an ELISA for the detection of antibodies against Erns envelope protein of classical swine fever virus. In: De Smit AJ, editor, Classical Swine Fever. Efficacy of Marker Vaccines and Laboratory Diagnosis. Ph.D. Thesis. Utrecht University; 2000, p. 117-31.
15. Edwards S., Fukusho A., Lefevre P.C., et al. Classical swine fever: the global situation. Vet Microbiol 73 2/3 (2000) 103-119
16. Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs. Vet Microbiol 83 2 (2001) 121-136
17. Goto H., and Lindoso J.A. Immunity and immunosuppression in experimental visceral leishmaniasis. Braz J Med Biol Res 37 4 (2004) 615-623
18. Greiser-Wilke I., Moennig V., Coulibaly C.O., Dahle J., Leder L., and Liess B. Identification of conserved epitopes on a hog cholera virus protein. Arch Virol 111 3/4 (1990) 213-225
19. Gupta R.K., and Siber G.R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13 14 (1995) 1263-1276
20. Guzylack-Piriou L., Balmelli C., McCullough K.C., and Summerfield A. Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. Immunology 112 1 (2004) 28-37
21. Guzylack-Piriou L., Piersma S.J., McCullough K.C., and Summerfield A. Role of natural interferon-producing cells and T lymphocytes in porcine monocyte-derived dendritic cell maturation. Immunology (2006)
22. Hertz C.J., Kiertscher S.M., Godowski P.J., et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 166 4 (2001) 2444-2450
23. Hoerauf A., Rollinghoff M., and Solbach W. Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted. Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism. Int Immunol 8 10 (1996) 1569-1575
24. Hulst M.M., Westra D.F., Wensvoort G., and Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol 67 9 (1993) 5435-5442
25. Inumaru S., Kokuho T., Denham S., et al. Expression of biologically active recombinant porcine GM-CSF by baculovirus gene expression system. Immunol Cell Biol 76 3 (1998) 195-201
26. Knoetig S.M., Summerfield A., Spagnuolo-Weaver M., and McCullough K.C. Immunopathogenesis of classical swine fever: role of monocytic cells. Immunology 97 2 (1999) 359-366
27. Konig M., Lengsfeld T., Pauly T., Stark R., and Thiel H.J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 69 10 (1995) 6479-6486
28. Leitao A., Malur A., Cartaxeiro C., et al. Bacterial lipoprotein based expression vectors as tools for the characterisation of African swine fever virus (ASFV) antigens. Arch Virol 145 8 (2000) 1639-1657
29. Leitao A., Malur A., Cornelis P., and Martins C.L. Identification of a 25-aminoacid sequence from the major African swine fever virus structural protein VP72 recognised by porcine cytotoxic T lymphocytes using a lipoprotein based expression system. J Virol Methods 75 1 (1998) 113-119
30. Lipowski A., Drexler C., and Pejsak Z. Safety and efficacy of a classical swine fever subunit vaccine in pregnant sows and their offspring. Vet Microbiol 77 1/2 (2000) 99-108
31. Mayer D., Thayer T.M., Hofmann M.A., and Tratschin J.D. Establishment and characterisation of two cDNA-derived strains of classical swine fever virus, one highly virulent and one avirulent. Virus Res 98 2 (2003) 105-116
32. Mittelholzer C., Moser C., Tratschin J.D., and Hofmann M.A. Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains. Vet Microbiol 74 4 (2000) 293-308
33. Moormann R.J., Bouma A., Kramps J.A., Terpstra C., and De Smit H.J. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol 73 2/3 (2000) 209-219
34. Nardin E.H., Calvo-Calle J.M., Oliveira G.A., et al. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. J Immunol 166 1 (2001) 481-489
35. Pauly T., Elbers K., Konig M., Lengsfeld T., Saalmuller A., and Thiel H.J. Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J Gen Virol 76 Pt 12 (1995) 3039-3049
36. Rau H., Revets H., Balmelli C., McCullough K.C., and Summerfield A. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo. Vet Res 37 1 (2006) 155-168
37. Re F., and Strominger J.L. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 173 12 (2004) 7548-7555
38. Revets H., Pynaert G., Grooten J., de Baetselier P., and Lipoprotein I. A TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol 174 2 (2005) 1097-1103
39. Ruggli N., Tratschin J.D., Mittelholzer C., and Hofmann M.A. Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA. J Virol 70 6 (1996) 3478-3487
40. Ruggli N., Tratschin J.D., Schweizer M., McCullough K.C., Hofmann M.A., and Summerfield A. Classical swine fever virus interferes with cellular antiviral defense: evidence for a novel function of N(pro). J Virol 77 13 (2003) 7645-7654
41. Sacks D.L., Scott P.A., Asofsky R., and Sher F.A. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol 132 4 (1984) 2072-2077
42. Smelt S.C., Cotterell S.E., Engwerda C.R., and Kaye P.M. B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol 164 7 (2000) 3681-3688
43. Stegeman A., Elbers A., de Smit H., Moser H., Smak J., and Pluimers F. The 1997-1998 epidemic of classical swine fever in the Netherlands. Vet Microbiol 73 2/3 (2000) 183-196
44. Summerfield A, Alves M, Ruggli N, de Bruin MG, McCullough KC. High interferon-α responses associated with depletion of lymphocytes and natural interferon producing cells during classical swine fever. J Interferon Cytokine Res, in press.
45. Summerfield A., Guzylack-Piriou L., Schaub A., et al. Porcine peripheral blood dendritic cells and natural interferon-producing cells. Immunology 110 4 (2003) 440-449
46. Summerfield A., and McCullough K.C. Porcine bone marrow myeloid cells: phenotype and adhesion molecule expression. J Leukoc Biol 62 2 (1997) 176-185
47. Suradhat S., Intrakamhaeng M., and Damrongwatanapokin S. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection. Vet Immunol Immunopathol 83 3/4 (2001) 177-189
48. Tapping R.I., Akashi S., Miyake K., Godowski P.J., and Tobias P.S. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 165 10 (2000) 5780-5787
49. Terpstra C., Bloemraad M., and Gielkens A.L. The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus. Vet Microbiol 9 2 (1984) 113-120
50. Terpstra C., and Wensvoort G. The protective value of vaccine-induced neutralising antibody titres in swine fever. Vet Microbiol 16 2 (1988) 123-128
51. Terpstra C., Woortmeyer R., and Barteling S.J. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch Tierarztl Wochenschr 97 2 (1990) 77-79
52. Thoma-Uszynski S., Kiertscher S.M., Ochoa M.T., et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 165 7 (2000) 3804-3810
53. Torlone V., Titoli F., and Gialletti L. Circulating interferon production in pigs infected with hog cholera virus. Life Sci 4 17 (1965) 1707-1713
54. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 96 4 (2003) 367-384
55. van Rijn P.A., Bossers A., Wensvoort G., and Moormann R.J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol 77 Pt 11 (1996) 2737-2745
56. Vitiello A., Ishioka G., Grey H.M., et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest 95 1 (1995) 341-349
57. Von Niederhausern B., Bertoni G., Hertig C., Pfister H., Peterhans E., and Pauli U. Cloning and expression in mammalian cells of porcine tumor necrosis factor alpha: examination of biological properties. Vet Immunol Immunopathol 38 1/2 (1993) 57-74